The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Central Nervous System Therapy Market Research Report 2025

Global Central Nervous System Therapy Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1693090

No of Pages : 96

Ask Your Query
Synopsis
The global Central Nervous System Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Central Nervous System Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Central Nervous System Therapy.
Report Scope
The Central Nervous System Therapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Central Nervous System Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Central Nervous System Therapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbvie
Alkermes
Allergan
AstraZeneca
BIAL
Bristol-myers Squibb
Eisai
Endo Pharmaceuticals
Eli Lilly and Company
Hoffmann-LA Roche
Segment by Type
Antidepressant Treatment
Antipsychotic Therapy
Other CNS Disorder
Segment by Application
Hospital
Clinic
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Central Nervous System Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Central Nervous System Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Central Nervous System Therapy Market Overview
1.1 Product Overview and Scope of Central Nervous System Therapy
1.2 Central Nervous System Therapy Segment by Type
1.2.1 Global Central Nervous System Therapy Market Value Comparison by Type (2024-2030)
1.2.2 Antidepressant Treatment
1.2.3 Antipsychotic Therapy
1.2.4 Other CNS Disorder
1.3 Central Nervous System Therapy Segment by Application
1.3.1 Global Central Nervous System Therapy Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Central Nervous System Therapy Market Size Estimates and Forecasts
1.4.1 Global Central Nervous System Therapy Revenue 2019-2030
1.4.2 Global Central Nervous System Therapy Sales 2019-2030
1.4.3 Global Central Nervous System Therapy Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Central Nervous System Therapy Market Competition by Manufacturers
2.1 Global Central Nervous System Therapy Sales Market Share by Manufacturers (2019-2024)
2.2 Global Central Nervous System Therapy Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Central Nervous System Therapy Average Price by Manufacturers (2019-2024)
2.4 Global Central Nervous System Therapy Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Central Nervous System Therapy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Central Nervous System Therapy, Product Type & Application
2.7 Central Nervous System Therapy Market Competitive Situation and Trends
2.7.1 Central Nervous System Therapy Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Central Nervous System Therapy Players Market Share by Revenue
2.7.3 Global Central Nervous System Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Central Nervous System Therapy Retrospective Market Scenario by Region
3.1 Global Central Nervous System Therapy Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Central Nervous System Therapy Global Central Nervous System Therapy Sales by Region: 2019-2030
3.2.1 Global Central Nervous System Therapy Sales by Region: 2019-2024
3.2.2 Global Central Nervous System Therapy Sales by Region: 2025-2030
3.3 Global Central Nervous System Therapy Global Central Nervous System Therapy Revenue by Region: 2019-2030
3.3.1 Global Central Nervous System Therapy Revenue by Region: 2019-2024
3.3.2 Global Central Nervous System Therapy Revenue by Region: 2025-2030
3.4 North America Central Nervous System Therapy Market Facts & Figures by Country
3.4.1 North America Central Nervous System Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Central Nervous System Therapy Sales by Country (2019-2030)
3.4.3 North America Central Nervous System Therapy Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Central Nervous System Therapy Market Facts & Figures by Country
3.5.1 Europe Central Nervous System Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Central Nervous System Therapy Sales by Country (2019-2030)
3.5.3 Europe Central Nervous System Therapy Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Central Nervous System Therapy Market Facts & Figures by Country
3.6.1 Asia Pacific Central Nervous System Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Central Nervous System Therapy Sales by Country (2019-2030)
3.6.3 Asia Pacific Central Nervous System Therapy Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Central Nervous System Therapy Market Facts & Figures by Country
3.7.1 Latin America Central Nervous System Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Central Nervous System Therapy Sales by Country (2019-2030)
3.7.3 Latin America Central Nervous System Therapy Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Central Nervous System Therapy Market Facts & Figures by Country
3.8.1 Middle East and Africa Central Nervous System Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Central Nervous System Therapy Sales by Country (2019-2030)
3.8.3 Middle East and Africa Central Nervous System Therapy Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Central Nervous System Therapy Sales by Type (2019-2030)
4.1.1 Global Central Nervous System Therapy Sales by Type (2019-2024)
4.1.2 Global Central Nervous System Therapy Sales by Type (2025-2030)
4.1.3 Global Central Nervous System Therapy Sales Market Share by Type (2019-2030)
4.2 Global Central Nervous System Therapy Revenue by Type (2019-2030)
4.2.1 Global Central Nervous System Therapy Revenue by Type (2019-2024)
4.2.2 Global Central Nervous System Therapy Revenue by Type (2025-2030)
4.2.3 Global Central Nervous System Therapy Revenue Market Share by Type (2019-2030)
4.3 Global Central Nervous System Therapy Price by Type (2019-2030)
5 Segment by Application
5.1 Global Central Nervous System Therapy Sales by Application (2019-2030)
5.1.1 Global Central Nervous System Therapy Sales by Application (2019-2024)
5.1.2 Global Central Nervous System Therapy Sales by Application (2025-2030)
5.1.3 Global Central Nervous System Therapy Sales Market Share by Application (2019-2030)
5.2 Global Central Nervous System Therapy Revenue by Application (2019-2030)
5.2.1 Global Central Nervous System Therapy Revenue by Application (2019-2024)
5.2.2 Global Central Nervous System Therapy Revenue by Application (2025-2030)
5.2.3 Global Central Nervous System Therapy Revenue Market Share by Application (2019-2030)
5.3 Global Central Nervous System Therapy Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbvie
6.1.1 Abbvie Corporation Information
6.1.2 Abbvie Description and Business Overview
6.1.3 Abbvie Central Nervous System Therapy Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbvie Central Nervous System Therapy Product Portfolio
6.1.5 Abbvie Recent Developments/Updates
6.2 Alkermes
6.2.1 Alkermes Corporation Information
6.2.2 Alkermes Description and Business Overview
6.2.3 Alkermes Central Nervous System Therapy Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Alkermes Central Nervous System Therapy Product Portfolio
6.2.5 Alkermes Recent Developments/Updates
6.3 Allergan
6.3.1 Allergan Corporation Information
6.3.2 Allergan Description and Business Overview
6.3.3 Allergan Central Nervous System Therapy Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Allergan Central Nervous System Therapy Product Portfolio
6.3.5 Allergan Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Corporation Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca Central Nervous System Therapy Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AstraZeneca Central Nervous System Therapy Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 BIAL
6.5.1 BIAL Corporation Information
6.5.2 BIAL Description and Business Overview
6.5.3 BIAL Central Nervous System Therapy Sales, Revenue and Gross Margin (2019-2024)
6.5.4 BIAL Central Nervous System Therapy Product Portfolio
6.5.5 BIAL Recent Developments/Updates
6.6 Bristol-myers Squibb
6.6.1 Bristol-myers Squibb Corporation Information
6.6.2 Bristol-myers Squibb Description and Business Overview
6.6.3 Bristol-myers Squibb Central Nervous System Therapy Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bristol-myers Squibb Central Nervous System Therapy Product Portfolio
6.6.5 Bristol-myers Squibb Recent Developments/Updates
6.7 Eisai
6.6.1 Eisai Corporation Information
6.6.2 Eisai Description and Business Overview
6.6.3 Eisai Central Nervous System Therapy Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eisai Central Nervous System Therapy Product Portfolio
6.7.5 Eisai Recent Developments/Updates
6.8 Endo Pharmaceuticals
6.8.1 Endo Pharmaceuticals Corporation Information
6.8.2 Endo Pharmaceuticals Description and Business Overview
6.8.3 Endo Pharmaceuticals Central Nervous System Therapy Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Endo Pharmaceuticals Central Nervous System Therapy Product Portfolio
6.8.5 Endo Pharmaceuticals Recent Developments/Updates
6.9 Eli Lilly and Company
6.9.1 Eli Lilly and Company Corporation Information
6.9.2 Eli Lilly and Company Description and Business Overview
6.9.3 Eli Lilly and Company Central Nervous System Therapy Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Eli Lilly and Company Central Nervous System Therapy Product Portfolio
6.9.5 Eli Lilly and Company Recent Developments/Updates
6.10 Hoffmann-LA Roche
6.10.1 Hoffmann-LA Roche Corporation Information
6.10.2 Hoffmann-LA Roche Description and Business Overview
6.10.3 Hoffmann-LA Roche Central Nervous System Therapy Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hoffmann-LA Roche Central Nervous System Therapy Product Portfolio
6.10.5 Hoffmann-LA Roche Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Central Nervous System Therapy Industry Chain Analysis
7.2 Central Nervous System Therapy Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Central Nervous System Therapy Production Mode & Process
7.4 Central Nervous System Therapy Sales and Marketing
7.4.1 Central Nervous System Therapy Sales Channels
7.4.2 Central Nervous System Therapy Distributors
7.5 Central Nervous System Therapy Customers
8 Central Nervous System Therapy Market Dynamics
8.1 Central Nervous System Therapy Industry Trends
8.2 Central Nervous System Therapy Market Drivers
8.3 Central Nervous System Therapy Market Challenges
8.4 Central Nervous System Therapy Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Central Nervous System Therapy Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Central Nervous System Therapy Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Central Nervous System Therapy Market Competitive Situation by Manufacturers in 2023
Table 4. Global Central Nervous System Therapy Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Central Nervous System Therapy Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Central Nervous System Therapy Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Central Nervous System Therapy Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Central Nervous System Therapy Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Central Nervous System Therapy, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Central Nervous System Therapy, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Central Nervous System Therapy, Product Type & Application
Table 12. Global Key Manufacturers of Central Nervous System Therapy, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Central Nervous System Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Therapy as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Central Nervous System Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Central Nervous System Therapy Sales by Region (2019-2024) & (K Units)
Table 18. Global Central Nervous System Therapy Sales Market Share by Region (2019-2024)
Table 19. Global Central Nervous System Therapy Sales by Region (2025-2030) & (K Units)
Table 20. Global Central Nervous System Therapy Sales Market Share by Region (2025-2030)
Table 21. Global Central Nervous System Therapy Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Central Nervous System Therapy Revenue Market Share by Region (2019-2024)
Table 23. Global Central Nervous System Therapy Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Central Nervous System Therapy Revenue Market Share by Region (2025-2030)
Table 25. North America Central Nervous System Therapy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Central Nervous System Therapy Sales by Country (2019-2024) & (K Units)
Table 27. North America Central Nervous System Therapy Sales by Country (2025-2030) & (K Units)
Table 28. North America Central Nervous System Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Central Nervous System Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Central Nervous System Therapy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Central Nervous System Therapy Sales by Country (2019-2024) & (K Units)
Table 32. Europe Central Nervous System Therapy Sales by Country (2025-2030) & (K Units)
Table 33. Europe Central Nervous System Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Central Nervous System Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Central Nervous System Therapy Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Central Nervous System Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Central Nervous System Therapy Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Central Nervous System Therapy Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Central Nervous System Therapy Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Central Nervous System Therapy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Central Nervous System Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Central Nervous System Therapy Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Central Nervous System Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Central Nervous System Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Central Nervous System Therapy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Central Nervous System Therapy Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Central Nervous System Therapy Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Central Nervous System Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Central Nervous System Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Central Nervous System Therapy Sales (K Units) by Type (2019-2024)
Table 51. Global Central Nervous System Therapy Sales (K Units) by Type (2025-2030)
Table 52. Global Central Nervous System Therapy Sales Market Share by Type (2019-2024)
Table 53. Global Central Nervous System Therapy Sales Market Share by Type (2025-2030)
Table 54. Global Central Nervous System Therapy Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Central Nervous System Therapy Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Central Nervous System Therapy Revenue Market Share by Type (2019-2024)
Table 57. Global Central Nervous System Therapy Revenue Market Share by Type (2025-2030)
Table 58. Global Central Nervous System Therapy Price (US$/Unit) by Type (2019-2024)
Table 59. Global Central Nervous System Therapy Price (US$/Unit) by Type (2025-2030)
Table 60. Global Central Nervous System Therapy Sales (K Units) by Application (2019-2024)
Table 61. Global Central Nervous System Therapy Sales (K Units) by Application (2025-2030)
Table 62. Global Central Nervous System Therapy Sales Market Share by Application (2019-2024)
Table 63. Global Central Nervous System Therapy Sales Market Share by Application (2025-2030)
Table 64. Global Central Nervous System Therapy Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Central Nervous System Therapy Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Central Nervous System Therapy Revenue Market Share by Application (2019-2024)
Table 67. Global Central Nervous System Therapy Revenue Market Share by Application (2025-2030)
Table 68. Global Central Nervous System Therapy Price (US$/Unit) by Application (2019-2024)
Table 69. Global Central Nervous System Therapy Price (US$/Unit) by Application (2025-2030)
Table 70. Abbvie Corporation Information
Table 71. Abbvie Description and Business Overview
Table 72. Abbvie Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Abbvie Central Nervous System Therapy Product
Table 74. Abbvie Recent Developments/Updates
Table 75. Alkermes Corporation Information
Table 76. Alkermes Description and Business Overview
Table 77. Alkermes Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Alkermes Central Nervous System Therapy Product
Table 79. Alkermes Recent Developments/Updates
Table 80. Allergan Corporation Information
Table 81. Allergan Description and Business Overview
Table 82. Allergan Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Allergan Central Nervous System Therapy Product
Table 84. Allergan Recent Developments/Updates
Table 85. AstraZeneca Corporation Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. AstraZeneca Central Nervous System Therapy Product
Table 89. AstraZeneca Recent Developments/Updates
Table 90. BIAL Corporation Information
Table 91. BIAL Description and Business Overview
Table 92. BIAL Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. BIAL Central Nervous System Therapy Product
Table 94. BIAL Recent Developments/Updates
Table 95. Bristol-myers Squibb Corporation Information
Table 96. Bristol-myers Squibb Description and Business Overview
Table 97. Bristol-myers Squibb Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Bristol-myers Squibb Central Nervous System Therapy Product
Table 99. Bristol-myers Squibb Recent Developments/Updates
Table 100. Eisai Corporation Information
Table 101. Eisai Description and Business Overview
Table 102. Eisai Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Eisai Central Nervous System Therapy Product
Table 104. Eisai Recent Developments/Updates
Table 105. Endo Pharmaceuticals Corporation Information
Table 106. Endo Pharmaceuticals Description and Business Overview
Table 107. Endo Pharmaceuticals Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Endo Pharmaceuticals Central Nervous System Therapy Product
Table 109. Endo Pharmaceuticals Recent Developments/Updates
Table 110. Eli Lilly and Company Corporation Information
Table 111. Eli Lilly and Company Description and Business Overview
Table 112. Eli Lilly and Company Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Eli Lilly and Company Central Nervous System Therapy Product
Table 114. Eli Lilly and Company Recent Developments/Updates
Table 115. Hoffmann-LA Roche Corporation Information
Table 116. Hoffmann-LA Roche Description and Business Overview
Table 117. Hoffmann-LA Roche Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Hoffmann-LA Roche Central Nervous System Therapy Product
Table 119. Hoffmann-LA Roche Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Central Nervous System Therapy Distributors List
Table 123. Central Nervous System Therapy Customers List
Table 124. Central Nervous System Therapy Market Trends
Table 125. Central Nervous System Therapy Market Drivers
Table 126. Central Nervous System Therapy Market Challenges
Table 127. Central Nervous System Therapy Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Central Nervous System Therapy
Figure 2. Global Central Nervous System Therapy Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Central Nervous System Therapy Market Share by Type in 2023 & 2030
Figure 4. Antidepressant Treatment Product Picture
Figure 5. Antipsychotic Therapy Product Picture
Figure 6. Other CNS Disorder Product Picture
Figure 7. Global Central Nervous System Therapy Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Central Nervous System Therapy Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Global Central Nervous System Therapy Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Central Nervous System Therapy Market Size (2019-2030) & (US$ Million)
Figure 13. Global Central Nervous System Therapy Sales (2019-2030) & (K Units)
Figure 14. Global Central Nervous System Therapy Average Price (US$/Unit) & (2019-2030)
Figure 15. Central Nervous System Therapy Report Years Considered
Figure 16. Central Nervous System Therapy Sales Share by Manufacturers in 2023
Figure 17. Global Central Nervous System Therapy Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Central Nervous System Therapy Players: Market Share by Revenue in 2023
Figure 19. Central Nervous System Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Central Nervous System Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Central Nervous System Therapy Sales Market Share by Country (2019-2030)
Figure 22. North America Central Nervous System Therapy Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Central Nervous System Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Central Nervous System Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Central Nervous System Therapy Sales Market Share by Country (2019-2030)
Figure 26. Europe Central Nervous System Therapy Revenue Market Share by Country (2019-2030)
Figure 27. Germany Central Nervous System Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Central Nervous System Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Central Nervous System Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Central Nervous System Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Central Nervous System Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Central Nervous System Therapy Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Central Nervous System Therapy Revenue Market Share by Region (2019-2030)
Figure 34. China Central Nervous System Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Central Nervous System Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Central Nervous System Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Central Nervous System Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Central Nervous System Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Central Nervous System Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Central Nervous System Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Central Nervous System Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Central Nervous System Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Central Nervous System Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Central Nervous System Therapy Sales Market Share by Country (2019-2030)
Figure 45. Latin America Central Nervous System Therapy Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Central Nervous System Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Central Nervous System Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Central Nervous System Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Central Nervous System Therapy Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Central Nervous System Therapy Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Central Nervous System Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Central Nervous System Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Central Nervous System Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Central Nervous System Therapy by Type (2019-2030)
Figure 55. Global Revenue Market Share of Central Nervous System Therapy by Type (2019-2030)
Figure 56. Global Central Nervous System Therapy Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Central Nervous System Therapy by Application (2019-2030)
Figure 58. Global Revenue Market Share of Central Nervous System Therapy by Application (2019-2030)
Figure 59. Global Central Nervous System Therapy Price (US$/Unit) by Application (2019-2030)
Figure 60. Central Nervous System Therapy Value Chain
Figure 61. Central Nervous System Therapy Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock